copyright and Wegovy, two recent developments in the field of weight management, have garnered significant attention for their impressive results. These medications, both belonging to a class called GLP-1 receptor agonists, work by enhancing the body's natural processes to minimize appetite and optimize insulin sensitivity. Early clinical trials h